HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rita Bonfiglio Selected Research

Calcinosis

1/2021Breast cancer metastasis to bone: From epithelial to mesenchymal transition to breast osteoblast-like cells.
12/2020Molecular Aspects and Prognostic Significance of Microcalcifications in Human Pathology: A Narrative Review.
1/2020BMP-2 Variants in Breast Epithelial to Mesenchymal Transition and Microcalcifications Origin.
11/2019Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition.
11/2019Negative prognostic value of intra-ductal fat infiltrate in breast cancer.
12/2018Breast microcalcifications: biological and diagnostic perspectives.
10/2018Breast osteoblast-like cells: a new biomarker for the management of breast cancer.
1/2018Radiological, Histological and Chemical Analysis of Breast Microcalcifications: Diagnostic Value and Biological Significance.
1/2018Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rita Bonfiglio Research Topics

Disease

12Breast Neoplasms (Breast Cancer)
01/2021 - 04/2016
9Calcinosis
01/2021 - 01/2018
7Prostatic Neoplasms (Prostate Cancer)
10/2022 - 10/2017
4Neoplasm Metastasis (Metastasis)
03/2022 - 01/2018
4Neoplasms (Cancer)
01/2020 - 01/2019
2Hypertension (High Blood Pressure)
11/2021 - 12/2019
2Inflammation (Inflammations)
12/2019 - 01/2019
1Carotid Artery Diseases
11/2021
1Diabetes Mellitus
11/2021
1Renal Insufficiency (Renal Failure)
11/2021
1Colitis
02/2021
1Disease Progression
03/2018
1Carcinoma (Carcinomatosis)
04/2016

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
03/2022 - 10/2018
6Biological ProductsIBA
11/2021 - 01/2018
2VimentinIBA
01/2020 - 04/2016
1Caspase 3 (Caspase-3)IBA
10/2022
1RadiopharmaceuticalsIBA
10/2022
1oxidized low density lipoproteinIBA
11/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
11/2021
1C-Reactive ProteinIBA
11/2021
1Dextran SulfateIBA
02/2021
1CalciumIBA
12/2020
1Phenobarbital (Luminal)FDA Link
01/2020
1DenosumabFDA Link
01/2020
1SmokeIBA
12/2019
1Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2019
1Calcium OxalateIBA
11/2019
1B7-H1 AntigenIBA
01/2019
1CytokinesIBA
01/2019
1calcium phosphateIBA
01/2018
1MagnesiumIBA
01/2018
1fluoromethylcholineIBA
01/2018
1Durapatite (Hydroxylapatite)IBA
01/2018
1NF-kappa B (NF-kB)IBA
04/2016
1CateninsIBA
04/2016

Therapy/Procedure

6Therapeutics
11/2021 - 10/2017
2Precision Medicine
08/2019 - 01/2019
1Oral Administration
02/2021
1Castration
01/2020
1Radiotherapy
01/2019